{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:08Z","timestamp":1791489668315,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12072-025-10906-3","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:45:29Z","timestamp":1757778329000},"page":"1347-1359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-4401","authenticated-orcid":false,"given":"Ming-Ling","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jur-Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien-Sing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy SJ","family":"Fann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"10906_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","volume":"402","author":"M Martinello","year":"2023","unstructured":"Martinello M, et al. Hepatitis C. Lancet. 2023;402:1085\u20131096","journal-title":"Lancet"},{"key":"10906_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","volume":"13","author":"A Lonardo","year":"2006","unstructured":"Lonardo A, et al. Hepatitis c and steatosis: a reappraisal. J Viral Hepat. 2006;13:73\u201380","journal-title":"J Viral Hepat"},{"key":"10906_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;78:1966\u20131986","journal-title":"J Hepatol"},{"key":"10906_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"et al","year":"2016","unstructured":"European Association for the Study of the Liver (EASL), et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402","journal-title":"J Hepatol."},{"key":"10906_CR5","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1073\/pnas.1003585107","volume":"107","author":"Y Huang","year":"2010","unstructured":"Huang Y, et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci U S A. 2010;107:7892\u20137897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10906_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbalip.2018.06.018","volume":"1864","author":"P Pingitore","year":"2019","unstructured":"Pingitore P, et al. The role of PNPLA3 in health and disease. Biochimica et Biophysica Acta (BBA). 2019;1864:900\u2013906","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10906_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/cas.16042","volume":"115","author":"J Tai","year":"2024","unstructured":"Tai J, et al. Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype. Cancer Sci. 2024;115:564\u2013574","journal-title":"Cancer Sci"},{"key":"10906_CR8","doi-asserted-by":"publisher","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","volume":"272","author":"GR Upchurch","year":"1997","unstructured":"Upchurch GR, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272:17012\u201317017","journal-title":"J Biol Chem"},{"key":"10906_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111\u2013113","journal-title":"Nat Genet"},{"key":"10906_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.17","volume":"6","author":"K Oniki","year":"2016","unstructured":"Oniki K, et al. The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease. Nutr Diabetes. 2016;6: e210","journal-title":"Nutr Diabetes"},{"key":"10906_CR11","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1111\/dom.15622","volume":"26","author":"ML Chang","year":"2024","unstructured":"Chang ML, et al. Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: a 3-year prospective cohort study. Diabetes Obes Metab. 2024;26:2969\u20132978","journal-title":"Diabetes Obes Metab"},{"key":"10906_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399\u2013401","journal-title":"Nature"},{"key":"10906_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182204","volume":"12","author":"CM Huang","year":"2017","unstructured":"Huang CM, et al. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C. PLoS ONE. 2017;12: e0182204","journal-title":"PLoS ONE"},{"key":"10906_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, et al. Liver Fibrosis, but No Other Histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389\u201397.e10","journal-title":"Gastroenterology"},{"key":"10906_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u20131030","journal-title":"J Hepatol"},{"key":"10906_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cmi.2019.06.018","volume":"26","author":"YT Cheng","year":"2020","unstructured":"Cheng YT, et al. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study. Clin Microbiol Infect. 2020;26:366\u2013372","journal-title":"Clin Microbiol Infect"},{"key":"10906_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jiph.2024.01.010","volume":"17","author":"ML Chang","year":"2024","unstructured":"Chang ML, et al. Long-term renal function alterations in hepatitis C patients with SVRs: impacts of therapies and mixed cryoglobulinemia. J Infect Public Health. 2024;17:486\u2013494","journal-title":"J Infect Public Health"},{"issue":"1","key":"10906_CR18","doi-asserted-by":"publisher","first-page":"2470128","DOI":"10.1080\/2162402X.2025.2470128","volume":"14","author":"ML Chang","year":"2025","unstructured":"Chang ML, et al. Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort study. Oncoimmunology. 2025;14(1):2470128","journal-title":"Oncoimmunology"},{"key":"10906_CR19","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.cgh.2020.01.018","volume":"18","author":"ML Chang","year":"2020","unstructured":"Chang ML, et al. Hepatitis flares are associated with better outcomes than no flare in patients with decompensated cirrhosis and chronic hepatitis B virus infection. Clin Gastroenterol Hepatol. 2020;18:2064-2072.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10906_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, et al. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523\u2013530","journal-title":"Bioinformatics"},{"key":"10906_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"10906_CR22","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225\u20132229","journal-title":"Science"},{"key":"10906_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/ijms17060803","volume":"17","author":"LE Adinolfi","year":"2016","unstructured":"Adinolfi LE, et al. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. Int J Mol Sci. 2016;17:803","journal-title":"Int J Mol Sci"},{"key":"10906_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cgh.2008.02.034","volume":"6","author":"IA Hanouneh","year":"2008","unstructured":"Hanouneh IA, et al. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2008;6:584\u2013589","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10906_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000282103","volume":"28","author":"S Mihm","year":"2010","unstructured":"Mihm S. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes. Dig Dis. 2010;28(1):280\u2013284","journal-title":"Dig Dis"},{"issue":"1","key":"10906_CR26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/21505594.2020.1838742","volume":"11","author":"ML Chang","year":"2020","unstructured":"Chang ML, et al. Altering retinol binding protein 4 levels in hepatitis C: inflammation and steatosis matter. Virulence. 2020;11(1):1501\u20131511","journal-title":"Virulence"},{"key":"10906_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2010.12.020","volume":"55","author":"T Cai","year":"2011","unstructured":"Cai T, et al. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol. 2011;55:529\u2013535","journal-title":"J Hepatol"},{"key":"10906_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ajcn\/85.5.1275","volume":"85","author":"LM Fischer","year":"2007","unstructured":"Fischer LM, et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr. 2007;85:1275\u20131285","journal-title":"Am J Clin Nutr"},{"key":"10906_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.582666","volume":"7","author":"D Pineda-Tenor","year":"2020","unstructured":"Pineda-Tenor D, et al. MTHFR rs1801133 polymorphism is associated with liver fibrosis progression in chronic hepatitis C: a retrospective study. Front Med. 2020;7: 582666","journal-title":"Front Med"},{"key":"10906_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/hep.20664","volume":"41","author":"LE Adinolfi","year":"2005","unstructured":"Adinolfi LE, et al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology. 2005;41:995\u20131003","journal-title":"Hepatology"},{"key":"10906_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643\u201354","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10906_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000183","volume":"7","author":"J Behari","year":"2023","unstructured":"Behari J, et al. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis. Hepatol Commun. 2023;7: e00183","journal-title":"Hepatol Commun"},{"issue":"1","key":"10906_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3350\/cmh.2024.0631","volume":"31","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, et al. Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations. Clin Mol Hepatol. 2025;31(1):74\u201389","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10906_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","volume":"65","author":"E Tr\u00e9po","year":"2016","unstructured":"Tr\u00e9po E, et al. PNPLA3 gene in liver diseases. J Hepatol. 2016;65(2):399\u2013412","journal-title":"J Hepatol"},{"key":"10906_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1440-1746.2011.06948.x","volume":"27","author":"T Tomoda","year":"2012","unstructured":"Tomoda T, et al. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study. J Gastroenterol Hepatol. 2012;27:797\u2013804","journal-title":"J Gastroenterol Hepatol"},{"key":"10906_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jvh.12871","volume":"25","author":"AJ Walker","year":"2018","unstructured":"Walker AJ, et al. Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review. J Viral Hepat. 2018;25:442\u2013456","journal-title":"J Viral Hepat"},{"key":"10906_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00535-020-01731-6","volume":"55","author":"D Miki","year":"2020","unstructured":"Miki D, et al. PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication. J Gastroenterol. 2020;55:1162\u20131170","journal-title":"J Gastroenterol"},{"key":"10906_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cca.2017.11.026","volume":"476","author":"G Ndrepepa","year":"2018","unstructured":"Ndrepepa G, et al. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clin Chim Acta. 2018;476:130\u2013138","journal-title":"Clin Chim Acta"},{"key":"10906_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1507\/endocrj.EJ13-0463","volume":"61","author":"BJ Kim","year":"2014","unstructured":"Kim BJ, et al. A higher serum gamma-glutamyl transferase level could be associated with an increased risk of incident osteoporotic fractures in Korean men aged 50 years or older. Endocr J. 2014;61:257\u2013263","journal-title":"Endocr J"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10906-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:20:13Z","timestamp":1766078413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10906-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10906"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10906-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approval for the research protocol was obtained from the Chang Gung Memorial Hospital institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained in writing from each patient, and the study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Chang Gung Memorial Hospital institutional review board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"No. of the study\/trial: IRB No: 104-7005B.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration"}},{"value":"Not Applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}